"InDACtion" vs "3+7" Induction in AML

NCT02172872 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

606

Enrollment

NETWORK

Sponsor class

Conditions

Acute Myeloid Leukemia (AML)

Interventions

DRUG: standard combination chemotherapy
DRUG: decitabine

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC

Collaborators

[object Object]
[object Object]